Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001511164-13-000237
Filing Date
2013-05-16
Accepted
2013-05-16 15:24:18
Documents
11
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K neurokineform10kjanuary3113c.htm 10-K 715582
2 EXHIBIT 31.1 neurokineexhibit311.htm EX-31 7801
3 EXHIBIT 31.2 neurokineexhibit312.htm EX-31 10475
4 EXHIBIT 32.1 neurokineexhibit321.htm EX-32 5761
5 EXHIBIT 32.2 neurokineexhibit322.htm EX-32 5742
  Complete submission text file 0001511164-13-000237.txt   3577339

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT neukf-20130131.xml EX-101.INS 481640
7 XBRL TAXONOMY EXTENSION SCHEMA neukf-20130131.xsd EX-101.SCH 46276
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neukf-20130131_cal.xml EX-101.CAL 5250
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neukf-20130131_def.xml EX-101.DEF 76323
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE neukf-20130131_lab.xml EX-101.LAB 174411
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neukf-20130131_pre.xml EX-101.PRE 160569
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 333-161157 | Film No.: 13850991
SIC: 2834 Pharmaceutical Preparations